Objective: To evaluate the frequency and risk factors associated with clinically significant
contrast-induced nephropathy (CIN) in patients undergoing non-emergent coronary …

Objectives The aim of the study was to assess the incidence, clinical predictors and outcome
of Contrast induced nephropathy (CIN) after percutaneous coronary interventions (PCI) in …

Contrast induced nephropathy (CIN) has become the third leading cause of hospital-
acquired acute kidney injury. We aimed to measure the incidence of (CIN) and to assess …

Background: Contrast induced nephropathy (CIN) is a potential stumbling block in
administration of contrast media. CIN has been defined as an elevation of serum creatinine …

Contrast-induced nephropathy (CIN) is the third leading cause of acute kidney injury in
hospitalized patients. The prevalence of CIN is reported to range from 0% to 50 …

Background: Contrast-induced nephropathy (CIN) represents an increasing healthcare
burden and challenge especially in the scenario of increasing frequency of diagnostic …

Background: Contrast induced nephropathy is a common form of acquired acute renal
failure after coronary angiography and percutaneous coronary intervention (PCI) and this is …

Contrast-induced nephropathy (CIN) is associated with significantly increased morbidity and
mortality after coronary angiography and percutaneous coronary intervention (PCI). The aim …

Contrast-induced nephropathy (CIN) is of concern after the use of radiocontrast media for
coronary angiography (CAG) and percutaneous coronary intervention (PCI). We studied the …

Background Contrast induced nephropathy (CIN) which is following the administration of
radiographic contrast media in coronary intervention results in increased morbidity and …